5.26
1.16%
0.0601
Schlusskurs vom Vortag:
$5.1999
Offen:
$5.48
24-Stunden-Volumen:
9,485
Relative Volume:
0.53
Marktkapitalisierung:
$199.29M
Einnahmen:
$7.80M
Nettoeinkommen (Verlust:
$-69.02M
KGV:
-2.6081
EPS:
-2.0168
Netto-Cashflow:
$-66.61M
1W Leistung:
+0.19%
1M Leistung:
-22.42%
6M Leistung:
+46.93%
1J Leistung:
+21.20%
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Firmenname
Molecular Partners Ag Adr
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie MOLN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
MOLN | 5.34 | 199.29M | 7.80M | -69.02M | -66.61M | -2.0168 |
VRTX | 450.30 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.35 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.08 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.34 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-08-30 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2022-08-29 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
2022-05-25 | Hochstufung | Credit Suisse | Underperform → Neutral |
2022-04-27 | Herabstufung | Credit Suisse | Neutral → Underperform |
2021-07-13 | Eingeleitet | Cowen | Outperform |
2021-07-12 | Fortgesetzt | SVB Leerink | Outperform |
Alle ansehen
Molecular Partners Ag Adr Aktie (MOLN) Neueste Nachrichten
Molecular Partners backs FY24 total expenses view of of CHF 65M-CHF 70M - TipRanks
Molecular Partners, Orano Med announce presentation of MP0712 data - TipRanks
Molecular Partners expands 212Pb co-development agreement with Orano Med - TipRanks
Molecular Partners shares gain on Leerink's outperform rating - Investing.com
Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket - Benzinga
Wall Street Analysts See a 96% Upside in Molecular Partners AG Sponsored ADR (MOLN): Can the Stock Really Move ... - Yahoo News UK
Molecular Partners to Present at The TD Cowen Radiopharmaceutical Innovation Summit - GlobeNewswire Inc.
Molecular Partners' New Therapy Shows AML Treatment PromiseTipRanks.com - TipRanks
Molecular Partners Unveils Promising Cancer Therapy - TipRanks
Why GameStop Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket By Benzinga - Investing.com UK
Molecular Partners Shares Rise on Positive Trial Data for MP0317 - MarketWatch
Rigel Pharmaceuticals names new Chief Medical Officer By Investing.com - Investing.com
Molecular Partners: Sellers Have Disappeared, Enterprise Value Below Zero (NASDAQ:MOLN) - Seeking Alpha
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.19% - Investing.com UK
US stock market gainers for the last week of April 2022 - Nairametrics
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com India
The Daily Biotech Pulse: Novartis COVID-19 Drug Readout, Merck And Roche Earnings, 3 IPOsiShares Biote - Benzinga
Molecular Partners (MLLCF) Stock Price, News & Analysis - MarketBeat
Market Data Center - Barron's
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
Finanzdaten der Molecular Partners Ag Adr-Aktie (MOLN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):